Home › Follicular Lymphoma › District of Columbia
Follicular Lymphoma clinical trials in District of Columbia
4 studies for Follicular Lymphoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
- HIPS, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07631598Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Georgetown University (Data Collection Only), Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT05389293A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 4 and older · All sexes · Updated Jun 25, 2026 · NCT04573140From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.